Literature DB >> 27311456

Prevention of the Post-Thrombotic Syndrome.

Teresa L Carman1.   

Abstract

OPINION STATEMENT: Post-thrombotic syndrome frequently affects patients following deep vein thrombosis. The clinical signs and symptoms of post-thrombotic syndrome reflect the underlying pathophysiology of venous obstruction, venous reflux as well as acute and chronic inflammation. Patients with post-thrombotic syndrome are at risk for long-term consequences including decreased quality of life, lost work productivity, and increased health expenditures. Unfortunately, despite recognition of pathophysiology and the clinical, physical, and economic impact of PTS, there have been few advances in prevention. PTS continues to be a frustrating condition to both prevent and manage. Preventing post-thrombotic syndrome begins with preventing deep vein thrombosis. In the setting of acute deep vein thrombosis-using available medical therapies to prevent the development of post-thrombotic syndrome is imperative. Patients should be provided optimal medical therapy with anticoagulation, maintaining therapeutic anticoagulation as much of the time as possible. Use of compression stockings, while contentious, are a low risk intervention which may provide benefit and are unlikely to be associated with harm. In the appropriate patient, considering endovenous procedures to decrease the thrombus burden and provide optimal preservation of venous valve function may be warranted.

Entities:  

Keywords:  Deep vein thrombosis; Post-thrombotic syndrome; Treatment; Vascular disease

Year:  2016        PMID: 27311456     DOI: 10.1007/s11936-016-0471-9

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  38 in total

1.  Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study.

Authors: 
Journal:  Circulation       Date:  2005-07-11       Impact factor: 29.690

2.  Predictors of post-thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiency.

Authors:  J P Galanaud; C A Holcroft; M A Rodger; M J Kovacs; M T Betancourt; P S Wells; D R Anderson; I Chagnon; G Le Gal; S Solymoss; M A Crowther; A Perrier; R H White; L M Vickars; T Ramsay; S R Kahn
Journal:  J Thromb Haemost       Date:  2013-03       Impact factor: 5.824

3.  Comparative outcomes of catheter-directed thrombolysis plus anticoagulation vs anticoagulation alone to treat lower-extremity proximal deep vein thrombosis.

Authors:  Riyaz Bashir; Chad J Zack; Huaqing Zhao; Anthony J Comerota; Alfred A Bove
Journal:  JAMA Intern Med       Date:  2014-09       Impact factor: 21.873

4.  Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial.

Authors:  Susan R Kahn; Stan Shapiro; Philip S Wells; Marc A Rodger; Michael J Kovacs; David R Anderson; Vicky Tagalakis; Adrielle H Houweling; Thierry Ducruet; Christina Holcroft; Mira Johri; Susan Solymoss; Marie-José Miron; Erik Yeo; Reginald Smith; Sam Schulman; Jeannine Kassis; Clive Kearon; Isabelle Chagnon; Turnly Wong; Christine Demers; Rajendar Hanmiah; Scott Kaatz; Rita Selby; Suman Rathbun; Sylvie Desmarais; Lucie Opatrny; Thomas L Ortel; Jeffrey S Ginsberg
Journal:  Lancet       Date:  2013-12-06       Impact factor: 79.321

5.  Prevention and treatment of postphlebitic syndrome: results of a 3-part study.

Authors:  J S Ginsberg; J Hirsh; J Julian; M Vander LaandeVries; D Magier; B MacKinnon; M Gent
Journal:  Arch Intern Med       Date:  2001-09-24

Review 6.  Long-term low-molecular-weight heparin and the post-thrombotic syndrome: a systematic review.

Authors:  Russell D Hull; Jane Liang; Grace Townshend
Journal:  Am J Med       Date:  2011-08       Impact factor: 4.965

7.  Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis.

Authors:  Suresh Vedantham; Samuel Z Goldhaber; Susan R Kahn; Jim Julian; Elizabeth Magnuson; Michael R Jaff; Timothy P Murphy; David J Cohen; Anthony J Comerota; Heather L Gornik; Mahmood K Razavi; Lawrence Lewis; Clive Kearon
Journal:  Am Heart J       Date:  2013-03-05       Impact factor: 4.749

8.  Low-dose low-molecular-weight heparin is anti-inflammatory during venous thrombosis.

Authors:  L J Downing; R M Strieter; A M Kadell; C A Wilke; L J Greenfield; T W Wakefield
Journal:  J Vasc Surg       Date:  1998-11       Impact factor: 4.268

9.  The effect of venous thrombus location and extent on the development of post-thrombotic signs and symptoms.

Authors:  Nicos Labropoulos; Thomas Waggoner; William Sammis; Saughar Samali; Peter J Pappas
Journal:  J Vasc Surg       Date:  2008-06-02       Impact factor: 4.268

10.  Effect of prolonged treatment with compression stockings to prevent post-thrombotic sequelae: a randomized controlled trial.

Authors:  Markus Aschwanden; Christina Jeanneret; Michael T Koller; Christoph Thalhammer; Heiner C Bucher; Kurt A Jaeger
Journal:  J Vasc Surg       Date:  2008-04-18       Impact factor: 4.268

View more
  1 in total

1.  Venous stent patency may be affected by collateral vein lumen size.

Authors:  Timme Maj van Vuuren; Suat Doganci; Irwin M Toonder; Rick De Graaf; Cees Ha Wittens
Journal:  Phlebology       Date:  2018-03-07       Impact factor: 1.740

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.